Delivery Order SPE2DB22D2206-SPE2DB25FEX09
Award Date
12/30/24
Potential Completion Date
12/31/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $4,385.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and medical supplier. The award is for the delivery of Cyclophosphamide 1 GM/5 ML VL 5ML, a critical pharmaceutical product, to support military treatment programs and facilities. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cyclophosphamide 2 GM/10 ML VL 10ML, a medication used in the treatment of various medical conditions. The contract has a ceiling value of $3,886.98 and a period of performance through April 18, 2025. This award is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of 4,566,110,527 units of Cyclophosphamide 2 GM vials. The contract has a ceiling value of $1,538.96 and is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to the Defense Logistics Agency (DLA). The $9,120.41 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a performance period ending on December 9, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,746.50 Firm Fixed Price Delivery Order covers the supply of 4566111213 - Cyclophosphamide 2 GM Vials, with a period of performance through October 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the delivery of Cyclophosphamide 500 mg vials, a critical pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,219.04 and an ultimate completion date of November 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,465.36 firm fixed-price contract is for the delivery of 2 gram vials of the drug Cyclophosphamide, with a completion date of November 15, 2024. The award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to support healthcare programs administered by the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with a ceiling value of $10,761.60 and a completion date of September 1, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of Cyclophosphamide 2 GM/10 ML VL 10ML, a critical pharmaceutical product. The contract has a ceiling value of $2,688.46 and runs through September 10, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies...
This federal contract award, valued at $1,156.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,517,983 units of Ifosfamide 3 GM Vials, a type of chemotherapy medication, with a completion date of February 2, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...